|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goebel C, Louden CL, McKenna R Jr, Onugha
O, Wachtel A and Long T: Diagnosis of non-small cell lung cancer
for early stage asymptomatic patients. Cancer Genomics Proteomics.
16:229–244. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang Q, Tang Y, Tang C, Cong H, Wang X,
Shen X and Ju S: Diminished LINC00173 expression induced miR-182-5p
accumulation promotes cell proliferation, migration and apoptosis
inhibition via AGER/NF-κB pathway in non-small-cell lung cancer. Am
J Transl Res. 11:4248–4262. 2019.PubMed/NCBI
|
|
4
|
Wang J, Su Z, Lu S, Fu W, Liu Z, Jiang X
and Tai S: LncRNA HOXA-AS2 and its molecular mechanisms in human
cancer. Clin Chim Acta. 485:229–233. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chi Y, Wang D, Wang J, Yu W and Yang J:
Long non-coding RNA in the pathogenesis of cancers. Cells.
8:10152019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu S, Zheng Q, Xiong J, Wu H, Wang W and
Zhou W: Long non-coding RNA MVIH promotes cell proliferation,
migration, invasion through regulating multiple cancer-related
pathways, and correlates with worse prognosis in pancreatic ductal
adenocarcinomas. Am J Transl Res. 12:2118–2135. 2020.PubMed/NCBI
|
|
7
|
Wang Y, Ding X, Hu H, He Y, Lu Z, Wu P,
Tian L, Xia T, Yin J, Yuan H, et al: Long non-coding RNA lnc-PCTST
predicts prognosis through inhibiting progression of pancreatic
cancer by downregulation of TACC-3. Int J Cancer. 143:3143–3154.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB,
Yin DD, Kong R, Xia R, Lu KH, Li JH, et al: Lnc RNA HOTAIR
functions as a competing endogenous RNA to regulate HER2 expression
by sponging miR-331-3p in gastric cancer. Mol Cancer. 13:922014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Leng X, Liu G, Wang S, Song J, Zhang W,
Zhang X, Rong L, Ma Y and Song F: LINC01272 promotes migration and
invasion of gastric cancer cells via EMT. Onco Targets Ther.
13:3401–3410. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang S, Hou Y, Chen W, Wang J, Xie W,
Zhang X and Zeng L: KIF9-AS1, LINC01272 and DIO3OS lncRNAs as novel
biomarkers for inflammatory bowel disease. Mol Med Rep.
17:2195–2202. 2018.PubMed/NCBI
|
|
11
|
Hung J, Scanlon JP, Mahmoud AD, Rodor J,
Ballantyne M, Fontaine MAC, Temmerman L, Kaczynski J, Connor KL,
Bhushan R, et al: Novel plaque enriched long noncoding RNA in
atherosclerotic macrophage regulation (PELATON). Arterioscler
Thromb Vasc Biol. 40:697–713. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Z, Sha HH and Li HJ: Functions and
mechanisms of miR-186 in human cancer. Biomed Pharmacother.
119:1094282019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Iacona JR and Lutz CS: miR-146a-5p:
Expression, regulation, and functions in cancer. Wiley Interdiscip
Rev RNA. 10:e15332019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mamoori A, Gopalan V and Lam AK: Role of
miR-193a in cancer: Complexity and factors control the pattern of
its expression. Curr Cancer Drug Targets. 18:618–628. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu B, Zhou W, Jiang H, Xiang Z and Wang
L: miR-1303 promotes the proliferation, migration and invasion of
prostate cancer cells through regulating the Wnt/β-catenin pathway
by targeting DKK3. Exp Ther Med. 18:4747–4757. 2019.PubMed/NCBI
|
|
16
|
Zhang SJ, Feng JF, Wang L, Guo W, Du YW,
Ming L and Zhao GQ: miR-1303 targets claudin-18 gene to modulate
proliferation and invasion of gastric cancer cells. Dig Dis Sci.
59:1754–1763. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lv QL, Wang LC, Li DC, Lin QX, Shen XL,
Liu HY, Li M, Ji YL, Qin CZ and Chen SH: Knockdown lncRNA DLEU1
inhibits gliomas progression and promotes temozolomide
chemosensitivity by regulating autophagy. Front Pharmacol.
11:5605432020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45((W1)):
W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Győrffy B, Surowiak P, Budczies J and
Lánczky A: Online survival analysis software to assess the
prognostic value of biomarkers using transcriptomic data in
non-small-cell lung cancer. PLoS One. 8:e822412013. View Article : Google Scholar
|
|
20
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Feng J, Li J, Qie P, Li Z, Xu Y and Tian
Z: Long non-coding RNA (lncRNA) PGM5P4-AS1 inhibits lung cancer
progression by up-regulating leucine zipper tumor suppressor
(LZTS3) through sponging microRNA miR-1275. Bioengineered.
12:196–207. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu W, Sun Z, Yang L, Han Y, Yue L, Deng L
and Yao R: lncRNA PTAR promotes NSCLC cell proliferation, migration
and invasion by sponging microRNA-101. Mol Med Rep. 20:4168–4174.
2019.PubMed/NCBI
|
|
23
|
Gao YP, Li Y, Li HJ and Zhao B: LncRNA
NBR2 inhibits EMT progression by regulating Notch1 pathway in
NSCLC. Eur Rev Med Pharmacol Sci. 23:7950–7958. 2019.PubMed/NCBI
|
|
24
|
Zhou Y, Shi H, Du Y, Zhao G, Wang X, Li Q,
Liu J, Ye L, Shen Z, Guo Y and Huang Y: lncRNA DLEU2 modulates cell
proliferation and invasion of non-small cell lung cancer by
regulating miR-30c-5p/SOX9 axis. Aging (Albany NY). 11:7386–7401.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Song JY, Li XP, Qin XJ, Zhang JD, Zhao JY
and Wang R: A fourteen-lncRNA risk score system for prognostic
prediction of patients with non-small cell lung cancer. Cancer
Biomark. 29:493–508. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu HY, Lu SR, Guo ZH, Zhang ZS, Ye X, Du
Q, Li H, Wu Q, Yu B, Zhai Q and Liu JL: lncRNA SLC16A1-AS1 as a
novel prognostic biomarker in non-small cell lung cancer. J
Investig Med. 68:52–59. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fang H, Yang L, Fan Y, Mo C, Luo L, Liang
D and Jiang Y: Upregulation of tissue long noncoding RNA X inactive
specific transcript predicts poor postoperative survival in
patients with non-small cell lung cancer. Medicine (Baltimore).
99:e217892020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang C, Gong C, Li J and Tang J:
Downregulation of long non-coding RNA LINC-PINT serves as a
diagnostic and prognostic biomarker in patients with non-small cell
lung cancer. Oncol Lett. 21:2102021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu W, Zhang H, Niu Y, Wu Y, Sun W, Li H,
Kong J, Ding K, Shen HM, Wu H, et al: Long non-coding RNA linc00673
regulated non-small cell lung cancer proliferation, migration,
invasion and epithelial mesenchymal transition by sponging
miR-150-5p. Mol Cancer. 16:1182017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu Q, Wu Y, Xiao J and Zou J: Long
non-coding RNA prostate cancer-associated transcript 7 (PCAT7)
induces poor prognosis and promotes tumorigenesis by inhibiting
mir-134-5p in non-small-cell lung (NSCLC). Med Sci Monit.
23:6089–6098. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
An YX, Shang YJ, Xu ZW, Zhang QC, Wang Z,
Xuan WX and Zhang XJ: STAT3-induced long noncoding RNA LINC00668
promotes migration and invasion of non-small cell lung cancer via
the miR-193a/KLF7 axis. Biomed Pharmacother. 116:1090232019.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Luo H, Xu C, Le W, Ge B and Wang T: lncRNA
CASC11 promotes cancer cell proliferation in bladder cancer through
miRNA-150. J Cell Biochem. 120:13487–13493. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Luan X and Wang Y: LncRNA XLOC_006390
facilitates cervical cancer tumorigenesis and metastasis as a ceRNA
against miR-331-3p and miR-338-3p. J Gynecol Oncol. 29:e952018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao W, Geng D, Li S, Chen Z and Sun M:
LncRNA HOTAIR influences cell growth, migration, invasion, and
apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer. Cancer
Med. 7:842–855. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen J, Jiang T, Yu B, Li T, Zhao P, Yuan
L and Qi J: Upregulation of microRNA-1303 is a potential prognostic
marker of non-small cell lung cancer. Cancer Biomark. 28:439–446.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liang Y, Song X, Li Y, Chen B, Zhao W,
Wang L, Zhang H, Liu Y, Han D, Zhang N, et al: LncRNA BCRT1
promotes breast cancer progression by targeting miR-1303/PTBP3
axis. Mol Cancer. 19:852020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zheng L, Liu YT, Wu CP, Jiang JT, Zhang L,
Wang ZL and Wang QY: Long non-coding RNA linc01433 promotes
tumorigenesis and progression in esophageal squamous cell carcinoma
by sponging miR-1301. Eur Rev Med Pharmacol Sci. 24:4785–4792.
2020.PubMed/NCBI
|
|
38
|
Cheng T, Shuang W, Ye D, Zhang W, Yang Z,
Fang W, Xu H, Gu M, Xu W and Guan C: SNHG16 promotes cell
proliferation and inhibits cell apoptosis via regulation of the
miR-1303-p/STARD9 axis in clear cell renal cell carcinoma. Cell
Signal. 84:1100132021. View Article : Google Scholar : PubMed/NCBI
|
